DENTSPLY SIRONA Inc. (XRAY) is a publicly traded Healthcare sector company. As of November 16, 2026, XRAY trades at $9.28 with a market cap of $1.83B and a P/E ratio of -2.93. XRAY moved +1.31% today. Year to date, XRAY is -18.72%; over the trailing twelve months it is -16.35%. Its 52-week range spans $8.14 to $17.18. Analyst consensus is neutral with an average price target of $10.64. Rallies surfaces XRAY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Dentsply Sirona cuts 2026 EPS outlook as Q3 adjusted EPS falls 31%: Dentsply Sirona’s Q3 revenue fell 7.6% year over year to $836 million, below the $862 million consensus, and adjusted EPS fell 31% to $0.29, below the 31-cent estimate. It cut 2026 adjusted EPS guidance to $1.20–$1.30 from $1.40–$1.50, excluding a 17-cent one-time tariff refund benefit.
| Metric | Value |
|---|---|
| Price | $9.28 |
| Market Cap | $1.83B |
| P/E Ratio | -2.93 |
| EPS | $-3.00 |
| Dividend Yield | 0.16% |
| 52-Week High | $17.18 |
| 52-Week Low | $8.14 |
| Volume | 10.67K |
| Avg Volume | 0 |
| Revenue (TTM) | $3.68B |
| Net Income | $-598.00M |
| Gross Margin | 50.00% |
11 analysts cover XRAY: 0 strong buy, 2 buy, 8 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $10.64.